meta_analysis
    2020
    High Quality

    Anti-Aβ agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis

    Unknown authors

    Published in J Neurol Neurosurg Psychiatry

    Key Findings

    Anti-amyloid agents reduced amyloid burden but produced only marginal cognitive benefit in mild to moderate Alzheimer disease.

    Conclusions

    Plaque reduction does not reliably translate into clinical gain.

    Outcomes Measured

    Amyloid Plaque Prevention
    Primary

    Anti-amyloid agents reduced amyloid burden but produced only marginal cognitive benefit in mild to moderate Alzheimer disease.

    Related Health Concerns

    Alzheimer's Disease

    Study Details

    Year:2020
    Quality Score:8/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.